The Department of War’s Office of Strategic Capital (OSC) has announced the National Security Fund Finance (NSFF) program, a new credit initiative aimed at shoring up U.S. critical minerals and materials that sit behind core national security technologies. Rather than adding another grant program for operators, NSFF is built to push capital into the system […]
NSFF: A New Pentagon Play for Critical Minerals Finance Read More »
The National Institutes of Health (NIH) is starting to roll out its new Unified Funding Strategy, originally announced in late 2025, to support more informed, transparent, and flexible funding decisions across its Institutes, Centers, and Offices. Peer review remains central to NIH’s process, but funding decisions will now draw on the full body of review
NIH’s Unified Funding Strategy Signals a New Approach to Award Decisions Read More »
The Administration for Strategic Preparedness and Response (ASPR) has quietly dropped one of the most important funding documents of the year: the 2025–2029 Public Health Emergency Medical Countermeasure Enterprise (PHEMCE) Multiyear Budget (MYB). On paper, it is a five‑year budget plan across: The Administration for Strategic Preparedness and Response (ASPR) The Biomedical Advanced Research and
ASPR’s New Five Year Plan: Reading the Fine Print on Medical Countermeasure Funding Read More »
The Advanced Research Projects Agency for Health (ARPA‑H) has released Special Notice ARPA‑H‑SN‑26‑156 under its Proactive Health Office (PHO), focusing on early clinical development of ibogaine for opioid use disorder (OUD). This Special Notice sits under ARPA‑H’s Proactive Health Office Innovative Solutions Opening (ISO PHO‑SOL‑24‑106), which is an open solicitation for “revolutionary solutions” that do not
ARPA-H’s Special Notice Supports Executive Order on Serious Mental Illness and OUD Read More »
Yesterday’s U.S. Senate Committee on Health, Education, Labor & Pensions (HELP) hearing put two key public health posts under the microscope: Sean Kaufman for Assistant Secretary for Preparedness and Response (ASPR) at the U.S. Department of Health and Human Services (HHS), and Dr. Erica Schwartz for Director of the Centers for Disease Control and Prevention
The Departments of Health and Human Services (HHS) and Veterans Affairs (VA) have entered a five‑year Memorandum of Understanding (MOU) to coordinate on rapid‑acting treatments for substance use disorders and mental health conditions in veterans, including psychedelic drug products. In parallel, the HHS/FDA and VA have signed MOU 225‑26‑007, which lays out how the agencies will collaborate and share information
HHS & VA’s MOU is Building the Data & Regulatory Backbone for Veterans’ Mental Health Read More »
The Defense Advanced Research Projects Agency (DARPA) Perrseus program is now live with a formal solicitation, moving from concept to concrete timelines and technical expectations. The goal hasn’t changed: build manufacturable, microscale ultra‑high‑vacuum (µUHV) packages that can support next‑generation quantum, MEMS, and photonics‑based sensors without relying on room‑sized vacuum systems. With the solicitation out, teams
DARPA’s Perrseus Program: Manufacturable µUHV for Quantum & Atomic Sensors Read More »
The Defense Advanced Research Projects Agency (DARPA), through its Biological Technologies Office (BTO), has released RFI DARPA‑SN‑26‑100 on “Multiscale Reasoning for Human Physiology.” The agency is seeking input from organizations that can connect human biology from molecules to clinical outcomes in support of military medicine. The focus is on prediction, diagnosis, intervention, and recovery in
New DARPA RFI: Multiscale Reasoning Across Human Physiology Read More »
The Defense Threat Reduction Agency (DTRA), under the Department of Defense, has updated its FY2022–2026 Chemical / Biological Technologies Broad Agency Announcement (BAA HDTRA122S0002) with Topic Call 7, adding two new applied research topics in biological threat detection. The BAA is an open, five-year contracting vehicle focused on Technology Readiness Level (TRL) 3–6 technologies, meaning
DTRA Topic Call 7: Advanced Bioaerosol Triggers and Engineered Genome Detection Read More »
Overview of the Opportunity The Biomedical Advanced Research and Development Authority (BARDA), through the Rapid Response Partnership Vehicle (RRPV), has released a new Request for Information (RFI) titled “Biosafety Level 4 Preclinical and Nonclinical Support for Medical Countermeasure Development (BSL4)”. Issued July 9, 2026, the RFI is a market research exercise to map out who can deliver preclinical and nonclinical
BARDA RRPV RFI Seeks Partners for BSL4 Studies and Support Services Read More »
Overview of the Opportunity The National Institute of Allergy and Infectious Diseases (NIAID), through the National Institutes of Health (NIH), has issued RFP No. BAA-75N93026R00008 for the Immune Mechanisms of Protection Against Mycobacterium tuberculosis Center (IMPAc‑TB), a five‑year contract program that renews the effort to accelerate TB vaccine development. The goal is to define tissue‑specific and
NIAID Renews IMPAc‑TB to Accelerate Tuberculosis Vaccine Development Read More »
The federal government is no longer treating quantum as a distant research project. It is building out the industrial base needed to manufacture quantum systems at scale. On June 28, 2026, the National Institute of Standards and Technology (NIST) announced an agreement with SRI International to establish the Quantum Manufacturing Engineering Center (QMEC). The center is focused on accelerating the
